-
Published 3/17/2025
Rasooly D, Pereira AC, Joseph J. Drug Discovery and Development for Heart Failure Using Multi-Omics Approaches. Int J Mol Sci. 2025 Mar 17; 26(6). PMID: 40141349.
-
Published 3/1/2025
Moinul S, Urina-Jassir M, Rodriguez-Taveras J, Peralta AO, Hoffmeister PS, Kinlay S, Yarmohammadi H, Boden WE, Joseph J, Yuyun MF. Meta-Analysis of Racial and Ethnic Disparities in Rhythm Control Strategies for Atrial Fibrillation in the United States. Am J Cardiol. 2025 Jun 15; 245:1-10. PMID: 40032171.
-
Published 2/6/2025
Rasooly D, Giambartolomei C, Peloso GM, Dashti H, Ferolito BR, Golden D, Horimoto ARVR, Pietzner M, Farber-Eger EH, Wells QS, Bini G, Proietti G, Tartaglia GG, Kosik NM, Wilson PWF, Phillips LS, Munroe PB, Petersen SE, Cho K, Gaziano JM, Leach AR, Whittaker J, Langenberg C, Aung N, Sun YV, Pereira AC, Casas JP, Joseph J. Large-scale multi-omics identifies drug targets for heart failure with reduced and preserved ejection fraction. Nat Cardiovasc Res. 2025 Mar; 4(3):293-311. PMID: 39915329.
-
Published 2/5/2025
Li Y, Nguyen XT, Treu T, Wang DD, Ho YL, Houghton SC, Charest B, Li R, Posner D, Pyatt M, Rahafrooz M, Raghavan S, Gagnon DR, Whitbourne SB, Gaziano JM, Djousse L, Joseph J, Wilson PWF, Cho K. Association of Life's Essential 8 With Incident Heart Failure and Its Prognosis. J Card Fail. 2025 Mar; 31(3):598-602. PMID: 39920917.
-
Published 7/9/2024
Kurgansky KE, Parker R, Djousse L, Gagnon DR, Joseph J. Spironolactone Reduces the Risk of Death in Veterans With Heart Failure With Preserved Ejection Fraction. J Am Heart Assoc. 2024 Jul 16; 13(14):e032231. PMID: 38979805.